SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Akzo Nobel N.V. (AKZOY) trades at a trailing P/E of 16.4, forward P/E of 15.2. Trailing earnings yield is 6.10%, forward earnings yield 6.59%. PEG 0.07 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (85/100, Pass) — P/E is below market average (16.4); PEG ≤ 1.0 — Peter Lynch undervalued (0.07); earnings yield beats bond yields (6.10%).
- Forward P/E 15.2 (down from trailing 16.4) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.07 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 6.10% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 6.59% as earnings recover.
Overall SharesGrow Score: 71/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
85/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AKZOY
Valuation Multiples
P/E (TTM)16.4
Forward P/E15.2
PEG Ratio0.07
Forward PEG1.87
P/B Ratio0.00
P/S Ratio1.07
EV/EBITDA0.0
Per Share Data
EPS (TTM)$1.23
Forward EPS (Est.)$1.33
Book Value / Share$0.00
Revenue / Share$18.90
FCF / Share$0.00
Yields & Fair Value
Earnings Yield6.10%
Forward Earnings Yield6.59%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.48 |
$14.2B |
$970M |
6.8% |
| 2017 |
$0.41 |
$9.61B |
$832M |
8.7% |
| 2018 |
$3.26 |
$9.26B |
$6.67B |
72.1% |
| 2019 |
$0.27 |
$9.28B |
$539M |
5.8% |
| 2020 |
$0.36 |
$8.53B |
$630M |
7.4% |
| 2021 |
$0.50 |
$9.59B |
$829M |
8.6% |
| 2022 |
$0.22 |
$10.85B |
$352M |
3.2% |
| 2023 |
$0.29 |
$10.67B |
$442M |
4.1% |
| 2024 |
$0.35 |
$10.71B |
$542M |
5.1% |
| 2025 |
$1.23 |
$9.76B |
$609.94M |
6.3% |
